Our preprint The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors was posted today.
Read the preprint. This is a preprint and has not yet been peer reviewed.
UPDATES
UPDATES
Our preprint The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors was posted today.
Read the preprint. This is a preprint and has not yet been peer reviewed.